Aadi Biosciences Stock Today

AADI -  USA Stock  

USD 21.92  2.59  10.57%

Market Performance
0 of 100
Odds Of Distress
Over 62
Aadi Biosciences is trading at 21.92 as of the 19th of January 2022. This is a -10.57 percent down since the beginning of the trading day. The stock's open price was 24.51. Aadi Biosciences has more than 62 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. Equity ratings for Aadi Biosciences are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 20th of December 2021 and ending today, the 19th of January 2022. Click here to learn more.
Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing precision therapies for genetically-defined cancers with alterations in mTOR pathway genes. The company was founded in 2011 and is headquartered in Pacific Palisades, California. The company has 20.89 M outstanding shares of which 235.69 K shares are presently shorted by private and institutional investors with about 0.91 trading days to cover. More on Aadi Biosciences

Aadi Biosciences Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. Aadi Biosciences' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Aadi Biosciences or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Aadi Biosciences is way too risky over 90 days horizon
Aadi Biosciences appears to be risky and price may revert if volatility continues
Aadi Biosciences has high likelihood to experience some financial distress in the next 2 years
Aadi Biosciences was previously known as Aerpio Pharmaceuticals and was traded on NCM Exchange under the symbol ARPO.
The company reported the previous year's revenue of 14.27 M. Net Loss for the year was (86.97 M) with loss before overhead, payroll, taxes, and interest of (428.36 K).
Aadi Biosciences currently holds about 161.38 M in cash with (13.27 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.72.
Aadi Biosciences has a frail financial position based on the latest SEC disclosures
Latest headline from www.marketbeat.com: Aadi Bioscience Upgraded by Zacks Investment Research to Hold - MarketBeat
Aadi Biosciences Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
Aadi Biosciences SEC Filings
Aadi Biosciences SEC Filings Security & Exchange Commission EDGAR Reports
Legal NameAadi Biosciences
Older SymbolARPO
Average Analyst Recommendation
Analysts covering Aadi Biosciences report their recommendations after researching Aadi Biosciences' financial statements, talking to executives and customers, or listening in on Aadi Biosciences' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Aadi Biosciences. The Aadi Biosciences consensus assessment is calculated by taking the average forecast from all of the analysts covering Aadi Biosciences.
Strong Buy4 Opinions
Piotroski F Score
Piotroski F-Score is a popular financial indicator that puts together nine criteria to evaluate the financial strength of Aadi Biosciences based on its profitability, leverage, liquidity, source of funds, and operating efficiency. It is an academic score (developed by Joseph Piotroski in 2002) to determine the current strength of Aadi Biosciences financial position. Scores of 8 and 9 are usually classified as strong value stocks, whereas scores of 2 or below are considered weak value stocks.
 3 - FrailDetails
Current ValueLast YearChange From Last Year 10 Year Trend
Weighted Average Shares2.7 M3.3 M
Significantly Down
Slightly volatile
Weighted Average Shares Diluted2.7 M3.3 M
Significantly Down
Slightly volatile
Total Assets25.5 M21.6 M
Fairly Up
Slightly volatile
Total Liabilities24.1 M28.1 M
Fairly Down
Slightly volatile
Current Assets25.3 M21.5 M
Fairly Up
Slightly volatile
Current Liabilities37.3 M34.6 M
Significantly Up
Slightly volatile
Total Debt9.5 M11.8 M
Significantly Down
Slightly volatile
Gross Margin0.890.9
Fairly Down
Slightly volatile
Asset Turnover0.460.46
Slightly volatile
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Aadi Biosciences' available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Cautious HoldUndervalued
Financial Strength
Aadi Biosciences' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Aadi Biosciences' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Aadi Biosciences' financial leverage. It provides some insight into what part of Aadi Biosciences' total assets is financed by creditors.
Share Download
Share Download
By using current balance sheet information, investors can analyze the liability, assets, and equity on Aadi Biosciences' books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Aadi Biosciences deploys its capital and how much of that capital is borrowed.
Aadi Biosciences cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company currently holds 613 K in liabilities with Debt to Equity (D/E) ratio of 0.0, which may suggest the company is not taking enough advantage from borrowing. Aadi Biosciences has a current ratio of 13.73, suggesting that it is liquid enough and is able to pay its financial obligations when due.

Operating Cash Flow

(5.23 Million)Share
Aadi Biosciences (AADI) is traded on NASDAQ Exchange in USA. It is located in 17383 Sunset Boulevard and employs 21 people. Aadi Biosciences was previously known as Aerpio Pharmaceuticals and was traded on NCM Exchange under the symbol ARPO. Aadi Biosciences is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with current market capitalization of 458 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Aadi Biosciences's market, we take the total number of its shares issued and multiply it by Aadi Biosciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Aadi Biosciences conducts business under Healthcare sector and is part of Biotechnology industry. The entity has 20.89 M outstanding shares of which 235.69 K shares are presently shorted by private and institutional investors with about 0.91 trading days to cover. Aadi Biosciences currently holds about 161.38 M in cash with (13.27 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.72.
Check Aadi Biosciences Probability Of Bankruptcy
Aadi Biosciences retains a total of 20.89 Million outstanding shares. Over half of Aadi Biosciences outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulation than regular investors in Aadi Biosciences. Please watch out for any change in the institutional holdings of Aadi Biosciences as this could mean something significant has changed or about to change at the company. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.

Ownership Allocation (%)

Check Aadi Biosciences Ownership Details

Aadi Biosciences Stock Price Odds Analysis

What are Aadi Biosciences' target price odds to finish over the current price? In reference to a normal probability distribution, the odds of Aadi Biosciences jumping above the current price in 90 days from now is about 64.21%. The Aadi Biosciences probability density function shows the probability of Aadi Biosciences stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 2.2872. This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Aadi Biosciences will likely underperform. In addition to that, the company has an alpha of 2.9413, implying that it can generate a 2.94 percent excess return over DOW after adjusting for the inherited market risk (beta).
 Odds Down 21.92HorizonTargetOdds Up 21.92 
35.71%90 days
Based on a normal probability distribution, the odds of Aadi Biosciences to move above the current price in 90 days from now is about 64.21 (This Aadi Biosciences probability density function shows the probability of Aadi Biosciences Stock to fall within a particular range of prices over 90 days) .

Aadi Biosciences Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Aadi Biosciences that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Aadi Biosciences' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Aadi Biosciences' value.
InstituionSecurity TypeTotal SharesValue
Avoro Capital Advisors LlcCommon Shares1.8 M53.7 M
Vr Adviser LlcCommon Shares1.5 M44.9 M
View Aadi Biosciences Diagnostics

Aadi Biosciences Historical Income Statement

Aadi Biosciences Income Statement is one of the three primary financial statements used for reporting Aadi Biosciences's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Aadi Biosciences revenue and expense. Aadi Biosciences Income Statement primarily focuses on the company's revenues and expenses during a particular period.
Aadi Biosciences Interest Expense is most likely to increase significantly in the upcoming years. The last year's value of Interest Expense was reported at 121,649. The current Research and Development Expense is estimated to increase to about 15.4 M, while Consolidated Income is projected to decrease to (4.2 M). View More Fundamentals

Aadi Biosciences Stock Against Markets

Picking the right benchmark for Aadi Biosciences stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Aadi Biosciences stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Aadi Biosciences is critical whether you are bullish or bearish towards Aadi Biosciences at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Aadi Biosciences without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Competition Analyzer Now


Competition Analyzer

Analyze and compare many basic indicators for a group of related or unrelated entities
All  Next Launch Module
Please continue to Trending Equities. Note that the Aadi Biosciences information on this page should be used as a complementary analysis to other Aadi Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Complementary Tools for Aadi Biosciences Stock analysis

When running Aadi Biosciences price analysis, check to measure Aadi Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aadi Biosciences is operating at the current time. Most of Aadi Biosciences' value examination focuses on studying past and present price action to predict the probability of Aadi Biosciences' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Aadi Biosciences' price. Additionally, you may evaluate how the addition of Aadi Biosciences to your portfolios can decrease your overall portfolio volatility.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Is Aadi Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aadi Biosciences. If investors know Aadi Biosciences will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aadi Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Aadi Biosciences is measured differently than its book value, which is the value of Aadi Biosciences that is recorded on the company's balance sheet. Investors also form their own opinion of Aadi Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Aadi Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aadi Biosciences' market value can be influenced by many factors that don't directly affect Aadi Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aadi Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine Aadi Biosciences value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aadi Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.